HCA Healthcare (NYSE:HCA) Price Target Increased to $390.00 by Analysts at Truist Financial

HCA Healthcare (NYSE:HCA) had its price objective boosted by Truist Financial from $375.00 to $390.00 in a report published on Wednesday, Benzinga reports. The firm currently has a buy rating on the stock.

HCA has been the topic of a number of other research reports. Barclays increased their price target on HCA Healthcare from $367.00 to $376.00 and gave the company an overweight rating in a research note on Wednesday, July 10th. Cantor Fitzgerald reissued an overweight rating and issued a $335.00 price target on shares of HCA Healthcare in a research note on Tuesday, July 9th. JPMorgan Chase & Co. raised their price objective on HCA Healthcare from $327.00 to $332.00 and gave the stock a neutral rating in a research note on Thursday, May 30th. Oppenheimer raised their price objective on HCA Healthcare from $330.00 to $345.00 and gave the stock an outperform rating in a research note on Monday, April 29th. Finally, Royal Bank of Canada raised their price objective on HCA Healthcare from $322.00 to $329.00 and gave the stock an outperform rating in a research note on Monday, April 29th. Four analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of Moderate Buy and an average target price of $339.72.

HCA Healthcare Stock Up 0.6 %

NYSE:HCA opened at $354.78 on Wednesday. The stock’s fifty day moving average price is $330.12 and its two-hundred day moving average price is $323.11. HCA Healthcare has a 52-week low of $215.96 and a 52-week high of $356.30. The company has a debt-to-equity ratio of 27.11, a quick ratio of 1.02 and a current ratio of 1.06. The company has a market cap of $92.92 billion, a price-to-earnings ratio of 17.69, a P/E/G ratio of 1.35 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The firm had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. During the same quarter in the prior year, the business earned $4.29 EPS. The business’s revenue for the quarter was up 10.3% compared to the same quarter last year. On average, analysts anticipate that HCA Healthcare will post 22.44 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s payout ratio is currently 13.16%.

Insider Buying and Selling

In related news, SVP Kathryn A. Torres sold 1,863 shares of HCA Healthcare stock in a transaction dated Wednesday, May 15th. The stock was sold at an average price of $326.18, for a total transaction of $607,673.34. Following the completion of the transaction, the senior vice president now owns 19,612 shares in the company, valued at $6,397,042.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other HCA Healthcare news, EVP Michael S. Cuffe sold 6,311 shares of the firm’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $316.88, for a total transaction of $1,999,829.68. Following the completion of the sale, the executive vice president now directly owns 29,624 shares in the company, valued at $9,387,253.12. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Kathryn A. Torres sold 1,863 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, May 15th. The shares were sold at an average price of $326.18, for a total transaction of $607,673.34. Following the completion of the sale, the senior vice president now owns 19,612 shares of the company’s stock, valued at $6,397,042.16. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 12,397 shares of company stock worth $3,921,929. Company insiders own 1.60% of the company’s stock.

Institutional Investors Weigh In On HCA Healthcare

Hedge funds and other institutional investors have recently made changes to their positions in the business. HB Wealth Management LLC increased its stake in HCA Healthcare by 37.0% in the second quarter. HB Wealth Management LLC now owns 4,273 shares of the company’s stock valued at $1,373,000 after acquiring an additional 1,155 shares during the last quarter. Kintegral Advisory LLC bought a new position in HCA Healthcare in the second quarter valued at approximately $2,290,000. Leith Wheeler Investment Counsel Ltd. increased its stake in HCA Healthcare by 24.4% in the second quarter. Leith Wheeler Investment Counsel Ltd. now owns 40,110 shares of the company’s stock valued at $12,887,000 after acquiring an additional 7,861 shares during the last quarter. AustralianSuper Pty Ltd increased its stake in HCA Healthcare by 7.7% in the second quarter. AustralianSuper Pty Ltd now owns 16,246 shares of the company’s stock valued at $5,220,000 after acquiring an additional 1,165 shares during the last quarter. Finally, Summit Securities Group LLC bought a new position in HCA Healthcare in the second quarter valued at approximately $260,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.